In contrast, in CRC, therapy with baicalein and polyisoprenylated benzophenones as anticancer agents in in-vitro indicated upregulation of DDIT4 associated with growth inhibition25,34. This evidence concerns the gene DDIT4 and colorectal carcinoma.